- Home
- NEUP
NEUP
Neuphoria Therapeutics Inc. Common Stock
as 03-31-2025 12:41pm EST
Stocks
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | EASTWOOD SA |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $21.00 | AVG Volume (30 days): | 47.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.12 - $15.24 | Next Earning Date: | 05-15-2025 |
| Revenue: | $662,715 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Neuphoria Therapeutics Inc. Common Stock News
NEUP Breaking Stock News: Dive into NEUP Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025
GlobeNewswire
2 months ago
Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck
Compare NEUP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NEUP Neuphoria Therapeutics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.